Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium

OBJECTIVES: In the present study, we explored the real-world efficacy of the immuno-oncology checkpoint inhibitor nivolumab and the tyrosine kinase inhibitor cabozantinib in the second-line setting. METHODS: Using the International Metastatic Renal Cell Carcinoma Database Consortium (imdc) dataset,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Curr Oncol
Hlavní autoři: Stukalin, I., Wells, J.C., Graham, J., Yuasa, T., Beuselinck, B., Kollmansberger, C., Ernst, D.S., Agarwal, N., Le, T., Donskov, F., Hansen, A.R., Bjarnason, G.A., Srinivas, S., Wood, L.A., Alva, A.S., Kanesvaran, R., Fu, S.Y.F., Davis, I.D., Choueiri, T.K., Heng, D.Y.C.
Médium: Artigo
Jazyk:Inglês
Vydáno: Multimed Inc. 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6476457/
https://ncbi.nlm.nih.gov/pubmed/31043824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4595
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky